STERIALS

A biopharmaceutical company committed to identifying and advancing innovative therapies for cancer and rare diseases. The company is pursuing development programs with investigational cell therapy drugs for the treatment of lymphatic malformations and non-muscle invasive bladder cancer, as well as developing a phospholipid substrate replacement therapy for parenteral nutrition patients with intestinal failure-associated liver disease. Based in Delaware.